Emilande Guichet - Concepedia

Author

Emilande Guichet

Université de Montpellier ORCID

Also Known As

A. Aghokeng, E Guichet, E. Guichet, Emilande GUICHET, Emilande Guichet, Guichet, Emilande, É. Guichet

Publications

617

Citations

H-Index

Concepts

All Affiliations

Université de Montpellier Institut de Recherche pour le Développement Inserm Central Hospital of Yaoundé National Radiation Protection Agency of Cameroon

About

Emilande Guichet is an author at Université de Montpellier specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	350
2	Public Health	1	1	23
3	Epidemiology	1	1	23
4	Global Health	1	1	71
5	Immunology	1	1	24

Emilande Guichet

Publications

529

Citations

H-Index

Page 1

	Year	Citations
African origin of the malaria parasite Plasmodium vivax Weimin Liu, Yingying Li, Katharina S. Shaw, Nature Communications MalariaVector-parasite RelationshipMedicinePlasmodium VivaxParasitology	2014	232
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial Laura Ciaffi, Sinata Koulla‐Shiro, Adrien Sawadogo, The Lancet HIV Lamivudine Dual TherapySuperiority TrialProtease InhibitorTreatment And PreventionGlobal Health	2017	71
High Prevalence of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (Anti–SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey Antoine Nkuba-Ndaye, Sheila Makiala‐Mandanda, Emilande Guichet, Clinical Infectious Diseases	2021	50
Deciphering Morphological Determinants of the Helix-Shaped Leptospira Leyla Slamti, Miguel A. de Pedro, Emilande Guichet, Journal of Bacteriology	2011	44
Short Communication: High Viral Load and Multidrug Resistance Due to Late Switch to Second-Line Regimens Could Be a Major Obstacle to Reach the 90-90-90 UNAIDS Objectives in Sub-Saharan Africa Emilande Guichet, Avelin F. Aghokeng, Laetitia Serrano, AIDS Research and Human Retroviruses	2016	30
In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa Christian Julián Villabona‐Arenas, Nicole Vidal, Emilande Guichet, AIDS	2016	27
Comparison of different nucleic acid preparation methods to improve specific HIV-1 RNA isolation for viral load testing on dried blood spots Emilande Guichet, Laetitia Serrano, Christian Laurent, Journal of Virological Methods Diagnostic VirologyViral LoadViral DiagnosticsHuman RetrovirusImmunology	2017	24
Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon Francis Atéba Ndongo, Emilande Guichet, Eric Mimbe, Emerging infectious diseases Pathogen PrevalenceVirus EpidemiologyEmerging Infectious DiseasesCovid-19 PandemicVirus Transmission	2022	23
Virologic Failure and Human Immunodeficiency Virus Drug Resistance in Rural Cameroon With Regard to the UNAIDS 90-90-90 Treatment Targets Charlotte Boullé, Emilande Guichet, Charles Kouanfack, Open Forum Infectious Diseases	2016	14
High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV) Abou Aissata Soumah, Mamadou Saliou Kalifa Diallo, Emilande Guichet, Open Forum Infectious Diseases	2022	14

Page 1